Get started
Author

Michael K. Rainer

Safety and immunogenicity of the tau vaccine AADvac1 in patients with Alzheimer's disease: a randomised, double-blind, placebo-controlled, phase 1 trial
2016 · Petr Novak, Reinhold Schmidt, et al. · The Lancet Neurology · 316
FUNDAMANT: an interventional 72-week phase 1 follow-up study of AADvac1, an active immunotherapy against tau protein pathology in Alzheimer’s disease
2018 · Petr Novak, Reinhold Schmidt, et al. · Alzheimer s Research & Therapy · 152
PDF
Risperidone long-acting injection: a review of its long term safety and efficacy
2008 · Michael Rainer · Neuropsychiatric Disease and Treatment · 68
PDF
Anatomical and functional changes in the retina in patients with Alzheimer’s disease and mild cognitive impairment
2020 · Stephan Szegedi, Peter Dal‐Bianco, et al. · Acta Ophthalmologica · 60
PDF
Clinical usefulness of dopamine transporter SPECT imaging with 123I-FP-CIT in patients with possible dementia with Lewy bodies: Randomised study
2014 · Zuzana Walker, Emilio Moreno, et al. · The British Journal of Psychiatry · 60
PDF
Genetic risk factors and markers for Alzheimer’s disease and/or depression in the VITA study
2008 · Edna Grünblatt, Sonja Zehetmayer, et al. · Journal of Psychiatric Research · 60
Galanthamine in Alzheimer??s Disease
1997 · Michael Rainer · CNS Drugs · 50
Secondary dementia due to Lyme neuroborreliosis
2018 · Wolfgang Kristoferitsch, Fahmy Aboulenein-Djamshidian, et al. · Wiener klinische Wochenschrift · 47
PDF
Effect of Risperidone on Behavioral and Psychological Symptoms and Cognitive Function in Dementia
2001 · Michael K. Rainer, Andreas J. Masching, et al. · The Journal of Clinical Psychiatry · 46
Risk Factors for Alzheimer Dementia in a Community-Based Birth Cohort at the Age of 75 Years
2008 · Peter Fischer, Sonja Zehetmayer, et al. · Dementia and Geriatric Cognitive Disorders · 45
Data From the VITA Study Do Not Support the Concept of Vascular Depression
2006 · Michael K. Rainer, H.A.M. Mucke, et al. · American Journal of Geriatric Psychiatry · 41
Sustained Effects of Once-Daily Memantine Treatment on Cognition and Functional Communication Skills in Patients with Moderate to Severe Alzheimer's Disease: Results of a 16-Week Open-Label Trial
2011 · Jörg B. Schulz, Michael Rainer, et al. · Journal of Alzheimer s Disease · 33
PDF
Late-Onset Depression in Elderly Subjects From the Vienna Transdanube Aging (VITA) Study
2009 · Nilufar Mossaheb, Silvia Weissgram, et al. · The Journal of Clinical Psychiatry · 30
Association of a Functional NOS1 Promoter Repeat with Alzheimer's Disease in the VITA Cohort
2011 · Andreas Reif, Edna Grünblatt, et al. · Journal of Alzheimer s Disease · 27
Are Specific Symptoms of Depression Predictive of Alzheimer’s Dementia?
2012 · Nilufar Mossaheb, Sonja Zehetmayer, et al. · The Journal of Clinical Psychiatry · 25
Ginkgo biloba extract EGb 761® in the treatment of dementia: a pharmacoeconomic analysis of the Austrian setting
2013 · Michael Rainer, Hermann Mucke, et al. · Wiener klinische Wochenschrift · 20
Evolution of clinical features in possible DLB depending on FP-CIT SPECT result
2016 · Zuzana Walker, Emilio Moreno, et al. · Neurology · 18
PDF
Genetic variation in the choline O-acetyltransferase gene in depression and Alzheimer’s disease: The VITA and Milano studies
2011 · Edna Grünblatt, Andreas Reif, et al. · Journal of Psychiatric Research · 18
Estrogen Receptor β Gene (ESRβ) 3′-UTR Variants in Alzheimer Disease
2006 · Christian Luckhaus, Christian Spiegler, et al. · Alzheimer Disease & Associated Disorders · 17
Disorder-specific effects of polymorphisms at opposing ends of the Insulin Degrading Enzymegene
2011 · Jasmin Bartl, Claus-Jürgen Scholz, et al. · BMC Medical Genetics · 14
PDF
Memantine in moderate to severe Alzheimer’s disease: an observational post-marketing study
2011 · Michael Rainer, A. Wuschitz, et al. · Journal of Neural Transmission · 13
[Transdermal rivastigmine patch in outpatient services in Austria: a naturalistic study in 103 patients with Alzheimer dementia].
2009 · Reinhold Schmidt, Claude Alf, et al. · PubMed · 13
Careful neuropsychological testing reveals a novel genetic marker,GSTO1*C, linked to the pre-stage of Alzheimer's disease
2016 · Ellen Umlauf, Eduard Rappold, et al. · Oncotarget · 11
PDF
Pflegende Angehörige von Demenzerkrankten: Belastungsfaktoren und deren Auswirkung
2002 · Michael Rainer, Susanne Jungwirth, et al. · Psychiatrische Praxis · 11
Effect of Six Months of Treatment with V0191 in Patients with Suspected Prodromal Alzheimer's Disease
2012 · Bruno Dubois, Mohammed Zaim, et al. · Journal of Alzheimer s Disease · 10
Works count: 59
Citation count: 1,259
H-index: 18
I10-index: 26
Year
Topic
Type